Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
doctor with overweight patient who may be treated with TAVR or surgery

Bariatric surgery improves heart health, survival in obese patients with obstructive sleep apnea

A team of Cleveland Clinic specialists tracked data from more than 13,000 patients, focusing on all-cause mortality and long-term cardiovascular outcomes.

doctor looking at CLTI patient's leg

FDA clears medical device company’s full line of vascular testing systems

The newly cleared devices are all designed to detect signs of PAD and/or PVD early enough that limb amputation is not required. 

Thumbnail

Spatial patterns on imaging could predict Alzheimer's years before cognitive symptoms emerge

These subtle changes precede greater tissue loss related to cognitive impairment.

stroke brain dementia alzheimer's puzzle mental health

Stroke after TAVR in AFib patients: Key risk factors cardiologists should know

Reviewing a patient's medical history can help care teams select the optimal post-TAVR oral anticoagulation strategy.

doctor examines patient data on their tablet

New CVD risk calculator could end statin therapy eligibility for millions of heart patients

The new PREVENT CVD risk calculator could result in more than 16 million heart patients who are no longer eligible for preventive therapy. These significant changes “carry the potential for both benefit and harm," researchers wrote in JAMA.

Sahil Parikh, MD, FSCAI, Director of Endovascular Services at New York-Presbyterian Columbia University Irving Medical Center, and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explains there is scant clinical data on what the standard of care should be for pulmonary embolism, so it is up to clinicians to decide what is best for patients based on whether patients have mild to severe PE.

Pulmonary embolism treatments continue to evolve

There is still a lack of lack of standardized treatment protocols for pulmonary embolism. This is mainly due to limited data and a lack of reliable risk assessments, one specialist explained.

Elixir Medical DynamX sirolimus-eluting coronary bioadaptor FDA

FDA grants drug-eluting bioadaptor its breakthrough device designation

The Elixir Medical DynamX sirolimus-eluting coronary bioadaptor is designed to improve coronary luminal diameter, help restore hemodynamic modulation and reduce plaque progression in patients with de novo coronary artery lesions.

Some weight loss patients are overdosing on semaglutide, FDA warns

Compounded semaglutide injectable products are at the heart of these concerns. While the FDA says compounded drugs “can serve an important medical need for patients,” the agency does not approve these new formulations, increasing the risk of complications. 

Displaying 369 - 376 of 5924
Design by Adaptive Theme